Search


SF Healthcare Week: Insitro CEO Daphne Koller on how AI is hitting “escape velocity” for finding causal targets for disease and speeding up drug development
An early pioneer in the space, she describes the current state of AI in life sciences and the progress that Insitro is making.
Jan 15


As biotech gravitates to machine learning and AI, insitro's founder shares her experience of working this way since 2018
Daphne Koller describes the platform insitro has been building since it was founded in 2018.
Feb 21, 2024






.png)
